In this world-first study, 24 participants took a cannabinoid medication, which contained THC and CBD, as well as another cannabinoid, cannabinol, CBN, for two weeks.
En este primer estudio mundial, 24 participantes tomaron un medicamento cannabinoide, que contenía THC y CBD, además de otro cannabinoide, el cannabinol, el CBN, durante dos semanas.